Postnatally diagnosed coexisting congenital diaphragmatic hernia with pulmonary sequestration: a report of two cases

Hyun Mi Kim1,2, Ja Hyun Hwang1,2, Mi Ju Kim1,3

  • 1Department of Obstetrics and Gynecology, School of Medicine, Kyungpook National University, Daegu, Korea.

Insights

Congenital diaphragmatic hernia (CDH) can be hidden by pulmonary sequestration (PS) on prenatal ultrasounds. Postnatal diagnosis is crucial, as PS may mask CDH, necessitating specialized delivery and imaging.

Area of Science:

  • Medical Science
  • Pediatric Surgery
  • Neonatology

Background:

  • Pulmonary sequestration (PS) and congenital diaphragmatic hernia (CDH) are known co-occurring conditions.
  • PS can obscure the prenatal diagnosis of CDH on ultrasonography, leading to delayed identification.
  • This masking effect can impact the management and outcomes of affected newborns.

Purpose of the Study:

  • To highlight the diagnostic challenge posed by PS masking CDH during prenatal screening.
  • To emphasize the importance of considering CDH in cases of isolated prenatally diagnosed PS.
  • To recommend appropriate management strategies for infants with suspected coexisting PS and CDH.

Main Methods:

  • Presentation of two case studies of newborns with postnatally diagnosed CDH and coexisting PS.
  • Review of prenatal ultrasonography findings and postnatal diagnostic confirmation.
  • Analysis of the potential role of PS as an "anatomical barrier" affecting lung development.

Main Results:

  • In both presented cases, PS was identified prenatally as an isolated lung mass.
  • CDH was only confirmed after birth, indicating it was initially overlooked due to the presence of PS.
  • Both newborns were stable postnatally, allowing for timely diagnosis and management planning.

Conclusions:

  • Pulmonary sequestration can act as a "protector" by preventing herniation and allowing normal lung maturation, but it may obscure coexisting congenital diaphragmatic hernia.
  • Prenatal suspicion of PS requires heightened vigilance for potential CDH, necessitating comprehensive parental counseling.
  • Infants with suspected coexisting PS and CDH should be delivered at tertiary centers with advanced imaging capabilities to exclude CDH and ensure appropriate care.

Related Concept Videos

Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
712
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
330
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
930
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
160
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
472
Esophageal Perforation-I: Introduction01:22

Esophageal Perforation-I: Introduction

Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
304